Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Formosa Pharmaceuticals Strikes Licensing Deal with Tabuk Pharmaceuticals for Clobetasol Propionate Ophthalmic Suspension

Taiwan-based Formosa Pharmaceuticals announced today that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing Company ("Tabuk"), for exclusive rights to the commercialization of clobetasol...

FDA Clears Rika Plasma Donation System's Individualized Nomogram

as part of an extensive ecosystem including the MyataTM Customer Service Portal and the KinariTM Device Management Platform, which enables electronic software distribution. All this is anticipated to support center productivity and efficiency to...

ONFAB, High Potent Containment Provider, Expands into USA Market

ISO 9001 accredited. the internationally recognized standard for an organization's internal quality management. For more information please visit https://onfab.co.uk/.

FDA Approves Myhibbin™ by Azurity Pharmaceuticals, Inc., a Mycophenolate Mofetil Oral Suspension

Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products to serve the needs of overlooked patients, announced that the U.S. Food and Drug Administration (FDA) has approved...

Adcentrx Therapeutics: China NMPA Clears IND for ADRX-0706, a Novel Nectin-4 ADC in Advanced Solid Tumor Treatment

Adcentrx's innovative i-Conjugation™ technology using a cleavable linker and stable conjugation chemistry. This novel platform technology enables a highly stable ADC with a drug-antibody ratio of eight (DAR 8) with a substantially expanded...

enGene to Showcase Pivotal Phase 1/2 LEGEND Study Details of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

ongoing Phase 2 pivotal study. EG-70 was developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and...

Axion BioSystems Adds Affordable Maestro Volt™ to its Industry-Leading MEA System Lineup

over time is essential in neurological and cardiovascular research. Axion BioSystems’ next-generation Maestro MEA platform, which also includes the high-throughput Maestro Pro™ and the versatile Maestro Edge™, makes it easy for any scientist to...

Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®

diseases. Wilate® is the first von Willebrand factor (VWF) concentrate indicated for prophylactic treatment across all forms of VWD, a significant patient treatment milestone for the most prevalent bleeding disorder in the United States. VWD...

Aurora enhances Australian offerings with premium dried flower range

as they continue to expand their offerings under the Aurora brand. The dried flower products are available now in four 10g formats including: "This expanded offering aims to serve patients with more choice, novel cultivars and expertly grown...

Cold Box Express, Inc. Introduces Refreshed Brand

Cold Box Express, Inc. (CBX) has announced a rebranding of both the company and its product the ClimateCrate™ (formerly COLD BOX). While the corporate company name remains Cold Box Express, Inc., the evolution to CBX simplifies the logo and helps...

TIVDAK® Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer

the first antibody-drug conjugate with statistically significant prolonged overall survival data.” The U.S. Prescribing Information for TIVDAK includes a BOXED WARNING for Ocular Toxicity as well as the following Warnings and Precautions:...

Avenacy announces launch of Eptifibatide for Injection in the U.S.

facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential medications. For more information, please visit http://www.avenacy.com/.

Medtronic, Heart-Valve-Surgery.Com launch 'Aortic Stenosis Patient Activation Platform

from Medtronic, a global leader in healthcare technology, today launched the "Aortic Stenosis Patient Activation Platform", an end-to-end digital platform for patient awareness, patient education, and patient activation specific to aortic valve...

Nature Publication Highlights the Benefits of Tropis® Intradermal

PharmaJet®, a company that strives to improve the performance and outcomes of medicines with its innovative delivery systems, announced the Nature publication1 of Gennova Biopharmaceutical’s Phase 2/3 clinical trial conducted to evaluate the...

VETIGEL is now available through all major U.S. distributors of veterinary products and services

and a wide range of surgical procedures. The veterinary hemostatic agent is made of two plant-based polysaccharides that form an instant mechanical barrier to stop bleeding on contact. Once the bleeding is controlled, VETIGEL can be easily removed...

Tentarix Biotherapeutics announces appointment of Andrew D. Kidd, MD, CFA, as CEO

to revolutionize patient care through multi-specific biologic treatments. The compelling science behind the Tentacles™ platform presents an unparalleled opportunity to impact the lives of patients globally. I am committed to harnessing this...

Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy

to promote health and improve lives. Factor Bioscience is privately held and headquartered in Cambridge, MA. For more information, visit www.factorbio.com.

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa

medicine, announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDM™. Platform, and the first company to make comprehensive genomic profiling and liquid biopsy widely available to patients throughout...

Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System

Hyalex Orthopaedics, a privately held medical device company developing cartilage repair products based on the transformative HYALEX® materials platform, announced that patients have successfully received HYALEX Knee Implants as part of the...

ImmunityBio Announces FDA Approval of ANKTIVA®,

natural immune system to defeat cancers and infectious diseases. The company’s range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection...